Dare Bioscience Inc
Change company Symbol lookup
Select an option...
DARE Dare Bioscience Inc
HEXEY Hellenic Exchanges Athens Stock Exchange SA
CLWA Fuzebox Software Corp
NGHC National General Holdings Corp
IVR Invesco Mortgage Capital Inc
CXP Columbia Property Trust Inc
TYTMF Tokyo Tatemono Co Ltd
ARPTF Airport City Ltd
KNSL Kinsale Capital Group Inc
EXLS Exlservice Holdings Inc

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.

Closing Price
Day's Change
0.04 (3.23%)
B/A Size
Day's High
Day's Low

10-day average volume:

Amazon's stock rallies toward 4th-straight record close

2:13 pm ET February 11, 2020 (MarketWatch)

Shares of Amazon.com Inc. (AMZN) rose 1.0% in afternoon trading Tuesday, to put them on track to close at a fourth straight record. The stock has run up 5.7% during the record streak, and has hiked 15.2% higher since the e-commerce and cloud giant reported https://www.marketwatch.com/story/amazon-earnings-return-to-growth-in-holiday-season-sending-stock-soaring-toward-1-trillion-valuation-2020-01-30. Since earnings were reported, Amazon has added $141.6 billion to its market capitalization to reach $1.07 trillion, to place the company in third place on the list of most valuable U.S. companies. Amazon is behind No. 1 Microsoft Corp. (MSFT) at $1.414 trillion and second-place Apple Inc. (AAPL) at $1.405 trillion, but above fourth-place Google-parent Alphabet Inc. (GOOGL) at $1.037 trillion. Amazon's is on the only stock of the four trillion-dollar companies that is gaining ground on Tuesday. Amazon's stock has now gained 21.7% over the past three months, while the Dow Jones Industrial Average has tacked on 5.8%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 11, 2020 14:13 ET (19:13 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.